Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn
08:41am, Thursday, 05'th Mar 2026
Investors who closely watch the healthcare sector are keeping an eye on Moderna ( NASDAQ:MRNA ) as its shares are up 12% over the past week and 95% year-to-date, trading near $56.67 as of March 4, 202
Market Today: Wall St. Rebounds; NVDA, AMZN, TGT in Focus
05:35pm, Wednesday, 04'th Mar 2026
Guru Stock PicksFairholme Fund has made the following transactions:Reduce in JOE by 0.23%David Tepper has made the following transactions:Reduce in WHR by 18.41
The Sun Will Shine On Moderna Again - Initiating With A Buy
03:16pm, Wednesday, 04'th Mar 2026
Moderna is initiated at a buy rating, as multiyear growth drivers and robust 2026 guidance signal a turnaround. mNEXSPIKE approvals, flu and combo vaccines, and mRNA therapeutics expansion underpin Mo
Stock Market Today: Major Indexes Surge After Sell-Off; Bitcoin, Crypto-Tied Stocks Soar
02:30pm, Wednesday, 04'th Mar 2026
Major stock indexes jumped Wednesday, a day after they fell but finished well above early lows, as Middle East fighting entered its fifth day.
Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom
11:05am, Wednesday, 04'th Mar 2026
Moderna, Inc. settles its LNP patent dispute with Arbutus and Genevant for a $950 million upfront payment, eliminating a major litigation overhang. MRNA secures royalty-free access to critical LNP tec
MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS
10:56am, Wednesday, 04'th Mar 2026
Moderna jumps after $2.25B settlement with Genevant and Arbutus over LNP patents tied to its COVID-19 and RSV vaccines, ending global litigation.
Moderna to pay up to $2.25B to settle COVID vaccine patent matter
10:20am, Wednesday, 04'th Mar 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock added almost 9% after it was announced that the drugmaker has agreed to pay up to $2.25 billion to settle a global patent infringement lawsuit brought by Arb
2 High-Flying Stocks With More Upside to Buy and Hold
09:12am, Wednesday, 04'th Mar 2026
Walmart is expertly navigating a challenging retail environment while continuing to grow its dividend. Moderna has a promising candidate that could hit the market in the near future.
Stock Futures Boosted by Middle East Headlines
09:11am, Wednesday, 04'th Mar 2026
Stocks are in rally mode today, as developments in the Middle East indicate oil price relief and an end to the conflict
Moderna and Ross Stores Lead Stock Gainers on Wednesday
08:40am, Wednesday, 04'th Mar 2026
Two stocks are standing out in premarket trading this Wednesday morning. Moderna (Nasdaq: MRNA) is up 8.9% and Ross Stores (Nasdaq: ROSS) is up 6.6% as of 8:00 AM ET, each moving on a distinct cataly
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
08:26am, Wednesday, 04'th Mar 2026
Moderna shares rose 10% in premarket trading on Wednesday after the company settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, removing an overhang and
Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars
08:14am, Wednesday, 04'th Mar 2026
Moderna Inc. (NASDAQ: MRNA) shares are up during Wednesday's premarket session following a settlement agreement with Arbutus Biopharma Corporation (NASDAQ: ABUS) and Roivant Inc.'s (NASDAQ: ROIV) Gene
First Look: Target (TGT), Paramount (PSKY) and Gold in Focus
07:38am, Wednesday, 04'th Mar 2026
Stock News Wall Street whipsawed by Mideast turmoil: The SPDR S&P 500 ETF Trust (SPY) fell Tuesday, then futures steadied as oil volatility and safeâhaven flo
Moderna Stock Rallies. This Big Risk Just Got Eliminated.
05:25am, Wednesday, 04'th Mar 2026
The company settles to resove patent litigation related to its Covid-19 vaccine, removing an overhang for shares.
Moderna Pops After Inking $950 Million Covid Vaccine Settlement
06:23pm, Tuesday, 03'rd Mar 2026
Moderna settled a yearslong patent dispute with Arbutus Biopharma and a subsidiary of Roivant Sciences. The news sent Moderna shares jumping.
